IRIS
RUSSO, CINZIA VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.611
NA - Nord America 3.362
EU - Europa 2.519
SA - Sud America 431
Continente sconosciuto - Info sul continente non disponibili 226
AF - Africa 111
OC - Oceania 5
Totale 10.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.227
SG - Singapore 1.521
RU - Federazione Russa 1.133
CN - Cina 687
VN - Vietnam 653
IT - Italia 522
BR - Brasile 326
HK - Hong Kong 321
DE - Germania 171
NL - Olanda 142
FR - Francia 129
GB - Regno Unito 98
FI - Finlandia 77
CA - Canada 76
IN - India 68
UA - Ucraina 62
BD - Bangladesh 52
JP - Giappone 51
AR - Argentina 50
IE - Irlanda 50
IR - Iran 43
KR - Corea 33
ZA - Sudafrica 33
CI - Costa d'Avorio 29
MX - Messico 28
PH - Filippine 24
AT - Austria 22
TH - Thailandia 22
ES - Italia 20
PL - Polonia 20
TR - Turchia 18
IQ - Iraq 17
PK - Pakistan 15
SE - Svezia 15
EC - Ecuador 13
ID - Indonesia 12
VE - Venezuela 12
LT - Lituania 11
BG - Bulgaria 10
TN - Tunisia 10
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
JO - Giordania 7
NP - Nepal 7
BO - Bolivia 6
CO - Colombia 6
EG - Egitto 6
JM - Giamaica 6
MY - Malesia 6
NI - Nicaragua 6
SA - Arabia Saudita 6
UY - Uruguay 6
AZ - Azerbaigian 5
BE - Belgio 5
KE - Kenya 5
UZ - Uzbekistan 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KW - Kuwait 4
LB - Libano 4
RS - Serbia 4
AL - Albania 3
AU - Australia 3
CH - Svizzera 3
DZ - Algeria 3
MA - Marocco 3
MN - Mongolia 3
MU - Mauritius 3
SN - Senegal 3
BB - Barbados 2
BZ - Belize 2
CG - Congo 2
EE - Estonia 2
GR - Grecia 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
PE - Perù 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AW - Aruba 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
Totale 10.020
Salva come PNG Salva come JPEG
Città #
Singapore 765
San Jose 519
Ashburn 337
Hong Kong 299
Moscow 283
Chandler 278
Beijing 199
Ho Chi Minh City 196
Santa Clara 155
Hefei 154
Hanoi 144
Amsterdam 119
Los Angeles 92
Naples 92
Lauterbourg 74
Dallas 71
Millbury 64
New York 56
The Dalles 54
Napoli 52
Des Moines 47
Nanjing 45
Tokyo 43
Princeton 40
Rome 40
Munich 35
São Paulo 35
Boston 33
Redondo Beach 32
Buffalo 31
London 27
Seattle 27
Frankfurt am Main 26
Houston 26
Da Nang 25
Seoul 25
Chicago 24
Denver 23
Lawrence 23
Montreal 23
Haiphong 22
Norwalk 22
Nuremberg 22
Helsinki 21
Wilmington 21
Turku 20
Warsaw 20
Council Bluffs 19
Toronto 19
Johannesburg 18
Milan 17
Orem 16
Brooklyn 15
Atlanta 13
Ottawa 13
Phoenix 13
Poplar 13
Pune 13
Tianjin 13
Cava De' Tirreni 12
Dong Ket 12
Dublin 12
Falkenstein 12
Vienna 12
Can Tho 11
Rio de Janeiro 11
San Francisco 11
Belo Horizonte 10
Biên Hòa 10
Nanchang 9
Redwood City 9
Sofia 9
Ankara 8
Chennai 8
Jacksonville 8
Manchester 8
Paris 8
Bangkok 7
Boardman 7
Fairfield 7
Hải Dương 7
Milwaukee 7
New Delhi 7
Porto Alegre 7
Quận Bình Thạnh 7
Shenyang 7
Stockholm 7
Washington 7
Amman 6
Caracas 6
Curitiba 6
Ha Long 6
Kronberg 6
Lahore 6
Lappeenranta 6
Miami 6
Newark 6
Querétaro 6
Quito 6
Shanghai 6
Totale 5.292
Salva come PNG Salva come JPEG
Nome #
Quality of Life and Cognitive function in pediatric and young adults multiple sclerosis: a cross-sectional study 236
Insulin Sensitivity and Early-Phase Insulin Secretion in Normoglycemic Huntington's Disease Patients 224
Uric acid: a potential biomarker of multiple sclerosis and of its disability 210
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 192
Cognitive decline in Huntington's disease expansion gene carriers 192
Multiple cranial neuropathy due to varicella zoster virus reactivation without vesicular rash: a challenging diagnosis 187
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 186
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 184
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 172
Modifications of resting state networks in spinocerebellar ataxia type 2 167
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 165
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression 165
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction 164
Prevalence and features of headache in Parkinson's disease: the role of dopamine 162
Prevalence and features of non-motor symptoms in Wilson's disease 159
Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry. 151
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. 150
Suicidal ideation in a European Huntington's disease population. 150
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. 150
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 149
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 148
Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease? 148
Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine 148
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C 147
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis 147
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients 145
Quality of life and cognitive function in pediatric and young multiple sclerosis patients: a cross-sectional study 143
Cognitive trajectories in multiple sclerosis: a long-term follow-up study 143
A real-world study of alemtuzumab in a cohort of Italian patients 142
Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study 141
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study 139
Cerebellar lobule atrophy and disability in progressive MS 139
A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine 136
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 133
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 133
Mobitz type I and II atrioventricular blocks during fingolimod therapy 132
Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study 132
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 131
The putative role of trigemino-vascular system in brain perfusion homeostasis and the significance of the migraine attack 130
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis 129
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis 129
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 128
A randomized clinical trial of lithium in multiple system atrophy. 127
Recurrent reflex syncope in idiopathic intracranial hypertension patient resolved after lumbar puncture: pathogenetic implications 126
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 122
Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome. 119
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 119
Olfactory function and cognition in relapsing–remitting and secondary-progressive multiple sclerosis 119
Molecular Genetics of Niemann-Pick Type C Disease in Italy: An Update on 105 Patients and Description of 18 NPC1 Novel Variants 118
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy? 118
Integration of the expanded disability status scale with ambulation, visual and cognitive tests 117
Comprehensive Evaluation of Plasma 7-Ketocholesterol and Cholestan-3β,5α,6β-Triol in an Italian Cohort of Patients Affected by Niemann-Pick Disease due to NPC1 and SMPD1 Mutations 117
A Novel PSEN1 Mutation in a Patient with Sporadic Early-Onset Alzheimer's Disease and Prominent Cerebellar Ataxia. 116
A longitudinal real-life comparison study of natalizumab and fingolimod 112
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 111
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study 111
Pulse pressure and presence of coronary artery calcification 110
A 8-year retrospective cohort study comparing Interferon-beta formulations for relapsing-remitting multiple sclerosis 110
The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis 110
Clinical manifestations of intermediate allele carriers in Huntington disease 110
A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosis 109
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 106
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington’s disease 105
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 96
The Framingham cardiovascular risk score in multiple sclerosis 95
Are anti-calcitonin gene-related peptide monoclonal antibodies effective in treating migraine aura? A pilot prospective observational cohort study 90
Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis 82
Cardiovascular profile improvement during Natalizumab treatment 80
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 80
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 77
Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis 76
Pregnancy outcomes in alemtuzumab treated women with multiple sclerosis: a case series 76
Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015 76
Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin 71
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion 65
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis 59
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study 57
Assessment of the Performance of a Modified Motor Scale as Applied to Juvenile Onset Huntington's Disease 53
Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series 50
null 45
β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease 43
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 14
BK polyomavirus-associated progressive multifocal leukoencephalopathy following mogamulizumab therapy for erythrodermic mycosis fungoides 10
Totale 10.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.467
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022418 0 3 9 4 11 24 8 21 55 37 99 147
2022/2023698 67 66 19 35 77 80 19 63 102 116 37 17
2023/2024497 25 73 45 32 28 51 49 66 7 10 78 33
2024/20252.548 100 128 20 31 79 155 304 175 114 312 927 203
2025/20264.997 532 345 521 514 922 191 592 230 573 352 130 95
2026/2027267 203 64 0 0 0 0 0 0 0 0 0 0
Totale 10.265